Oklahoma City biotech startup seeks funding for clinical trials

Oklahoma City’s EpimedX trying to develop treatment for sickle cell disease, which affects more than 90,000 people in the United States.

BY BRIANNA BAILEY Published: January 10, 2013
Advertisement
;

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the United States.

“Sickle cell...

Oklahoman subscribers have access to this article. Unlock it below.

What is this? Learn more.

NewsOK.com has disabled the comments for this article.

Trending Now


AROUND THE WEB

  1. 1
    Oklahoma State's Justin Gilbert signs his rookie contract with the Cleveland Browns
  2. 2
    Tulsa police believe mother, teen son planned deaths together
  3. 3
    Kevin Durant asks for your basketball videos in Summer is Serious 2
  4. 4
    Big 12 basketball: Time, TV listing announced for Sooners' December game against Washington
  5. 5
    Lawsuit: 'Duck Dynasty' stole 'camo' idea
+ show more